undefined undefined
NaN.000
NaN.00%
受益于药物需求持续增长,礼来(LLY.US)和诺和诺德(NVO.US)股价近几个月持续上涨,SA分析师发表相应评价
05-20 10:58
Shares of Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) have soared in recent months, fueled by skyrocketing demand for the companies’ respective weight-loss/diabetes drugs tirzepatide, also known as Mo...
05-20 03:05
01 大盘 昨夜美股三大股指涨跌不一,法拉第未来跌超37%。截至收盘,道指涨 0.34%,纳指跌 0.07%,标普涨 0.12%。美国十年国债收益率涨 1.0...
05-18 06:51
Cantor Fitzgerald initiates coverage on AbbVie with an Overweight rating and a $200 price target. AbbVie is set to manage Humira biosimilar erosion, drive growth with Skyrizi, Rinvoq, and emraclidine, and achieve a high single-digit CAGR from 2024 to 2029.
05-18 01:47
Amidst today's fast-paced and highly competitive business environment, it is cr...
05-17 23:00
5 analysts have expressed a variety of opinions on AbbVie (NYSE:ABBV) over the ...
05-17 21:00
Cantor Fitzgerald analyst Louise Chen initiates coverage on AbbVie (NYSE:ABBV) with a Overweight rating and announces Price Target of $200.
05-17 19:16
艾伯维(ABBV.US)递交的upadacitinib片拟纳入突破性治疗品种,拟用于治疗12岁及以上的青少年和成人非节段型白癜风患者。
05-17 15:37
On Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical companies who announced they will be investing a total of nearly $1 billion in their operations in France, just ahead of this year’s “Choose Franc
05-16 20:51
ACM Research, AT&T, and AbbVie are the 3 Best Value Stocks to buy in May 20...
05-15 19:20